Clinical Trial: Safety and Efficacy of MK-1200 in Participants With Advanced Solid Tumors

U.S., Feb. 5 -- ClinicalTrials.gov registry received information related to the study (NCT06242691) titled 'Safety and Efficacy of MK-1200 in Participants With Advanced Solid Tumors' on Jan. 26.

Brief Summary: The purpose of this study is to assess the efficacy and safety of MK-1200 monotherapy in participants with advanced/metastatic gastric/gastroesophageal junction (GEJ) cancer, esophageal cancer, biliary tract cancer, and pancreatic ductal adenocarcinoma who have received, or been intolerant to, all treatments known to confer clinical benefit. Part 1 of the study will be a dose escalation to determine the maximum tolerated dose (MTD). Part 2 will evaluate safety and efficacy of MK-1200 at 2 different doses

Study Type: Interventional ...